Compare · ATS vs DHR
ATS vs DHR
Side-by-side comparison of ATS Corporation (ATS) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATS and DHR operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $144.26B, about 53.3x ATS ($2.71B).
- Over the past year, ATS is down 11.6% and DHR is up 7.2% - DHR leads by 18.8 points.
- DHR has been more active in the news (7 items in the past 4 weeks vs 1 for ATS).
- DHR has more recent analyst coverage (25 ratings vs 4 for ATS).
- Company
- ATS Corporation
- Danaher Corporation
- Price
- $27.68-0.13%
- $203.75-0.62%
- Market cap
- $2.71B
- $144.26B
- 1M return
- -1.48%
- +12.32%
- 1Y return
- -11.62%
- +7.23%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2023
- News (4w)
- 1
- 7
- Recent ratings
- 4
- 25
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest ATS
- SEC Form 6-K filed by ATS Corporation
- Desjardins initiated coverage on ATS Corp
- SEC Form 6-K filed by ATS Corporation
- ATS to Participate in the Stifel Summer Solstice Conference
- SEC Form 6-K filed by ATS Corporation
- SEC Form 40-F filed by ATS Corporation
- ATS Reports Fourth Quarter Fiscal 2026 Results
- SEC Form 6-K filed by ATS Corporation
- ATS to Host Fourth Quarter Earnings Call Thursday May 28, 2026, at 8:30 a.m. Eastern
- SEC Form F-X filed by ATS Corporation
Latest DHR
- VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 60 shares, decreasing direct ownership by 0.65% to 9,107 units (SEC Form 4)
- Director Filler Linda exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 9% to 26,829 units (SEC Form 4)
- Director Zerhouni Elias A. exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 45,303 units (SEC Form 4)
- Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems
- Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- SEC Form 11-K filed by Danaher Corporation
- Piper Sandler initiated coverage on Danaher with a new price target
- Danaher Completes Acquisition of Masimo Corporation